Following DNMT1 knock-down or 5-aza-dC treatment, downregulation of SOX2 and reactivation of CSC inhibitory miRNAs might partially contribute to the inhibition of ESCC-CSCs, but the exact mechanism need a further study. The gene discussed is DNMT1; the disease is esophageal squamous cell carcinoma.